Welcome to the Mississippi Board of Pharmacy

The Mississippi Board of Pharmacy was established by legislative action in 1920. The mission of the Board is to protect and promote the health of Mississippi citizens by regulating and controlling the practice of pharmacy and the distribution of prescription drugs and devices. Our Board is comprised of seven pharmacist members, all appointed by the Governor. They are assisted by administrative staff headed by an Executive Director appointed by the Board. 


WIC + Pharmacies | 6/25/2020

The Mississippi WIC Program is looking for licensed pharmacies in the state of Mississippi to join our team. Pharmacies are asked to apply for the Mississippi WIC Program to provide specialized medical formula and nutritionals to WIC participants. Within the past month, you may have received a mailer from the MSDH WIC Program. The mailer contained a USB drive with additional information about the program.

To apply, please complete a vendor application located at www.freshnewwic.com. Pharmacies are required to submit the vendor application, Form W-9, proof of ownership (copy of lease, deed, bill of sale, etc.), pharmacy price survey, vendor technology survey, and a copy of the pharmacy license. The pharmacy price survey and vendor technology survey can also be found at www.freshnewwic.com.

Please view the attached flyer for more details. If you have any questions or concerns, please feel free to email the Mississippi WIC Vendor Management Team at vmu@msdh.ms.gov. 

WIC + Pharmacies Flyer​

July 2020 Board Meeting | 6/19/2020

2020 CE Requirements Update | 5/13/2020

Change to Mississippi CE Requirements for 2020 
During the Meeting of the Mississippi Board of Pharmacy on May 12, 2020, the Board unanimously agreed to suspend the LIVE Continuing Education Requirement for pharmacists in 2020. Pharmacists, upon request, will still be required to submit evidence of five (5) hours of opioid abuse and prevention/ drug of abuse/ addiction-related issues and a total of 15 hours for the year 2020.

The Script Volume 4 April 2020 | 4/8/2020

A new issue of The Script, the Mississippi Board of Pharmacy's quarterly newsletter, is out! Click Here to view the latest issue. We encourage you to make this available to your employees and would love to hear your feedback!​​

DEA Decision Tree | 4/1/2020

In response to the COVID-19 public health emergency declared by the Secretary of Health and Human Services, the Drug Enforcement Administration (DEA) has adopted policies to allow DEA-registered practitioners to prescribe controlled substances without having to interact in-person with their patients.  This chart only addresses prescribing controlled substances and does not address administering or direct dispensing of controlled substances, including by narcotic treatment programs (OTPs) or hospitals.  These policies are effective beginning March 31, 2020, and will remain in effect for the duration of the public health emergency, unless DEA specifies an earlier date.

This decision tree merely summarizes the policies for quick reference and does not provide a complete description of all requirements.  Full details are on DEA’s COVID-19 website (https://www.deadiversion.usdoj.gov/coronavirus.html​), and codified in relevant law and regulations.
Under federal law, all controlled substance prescriptions must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his/her professional practice.  21 CFR 1306.04(a).  In all circumstances when prescribing a controlled substance, including those summarized below, the practitioner must use his/her sound judgment to determine that s/he has sufficient information to conclude that the issuance of the prescription is for a bona fide medical purpose.  Practitioners must also comply with applicable state law.

1 - 5 Next

View all news >>​​​​​​​​​​​​​​​​​​​